glp-1 drugs and dementia Medications Associated with Reduced Likelihood of Compared to Other Diabetic Meds The expanding landscape of GLP-1
Description
Effects of miglitol, acarbose, and sitagliptin on plasma insulin and gut peptides in type 2 diabetes mellitus: a crossover study

Osteoporos Int

doi: 10.1016/j.metabol.2019.154031

Metabolic Brain Disease
